AWM Investment Company’s Definium Therapeutics DFTX Stock Holding History

AWM Investment Company’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4M	Sell	1,076,893 -313,769	-23%	-$5.32M	2.25%	12
2025 Q4	$18.6M	Buy	1,390,662 +175,000	+14%	+$2.17M	1.8%	21
2025 Q3	$14.3M	Hold	1,215,662	–	–	1.34%	23
2025 Q2	$7.89M	Buy	1,215,662 +7,500	+0.6%	+$49.3K	0.88%	43
2025 Q1	$7.07M	Buy	1,208,162 +15,000	+1%	+$107K	0.97%	42
2024 Q4	$8.3M	Buy	1,193,162 +340,162	+40%	+$2.34M	1.01%	39
2024 Q3	$4.85M	Buy	853,000 +20,000	+2%	+$139K	0.59%	51
2024 Q2	$6.01M	Hold	833,000	–	–	0.81%	41
2024 Q1	$7.83M	Buy	+833,000	New	+$4.75M	1.03%	35

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AWM Investment Company's DFTX Position: Q1 2026 in Review

AWM Investment Company reduced its Definium Therapeutics (DFTX) stake by 23% in Q1 2026, selling an estimated $5.32M and leaving 1,076,893 shares worth $20.4M. The position accounts for 2.25% of the portfolio, ranked #12.

AWM Investment Company first reported a position in DFTX in Q1 2024 and has held it in 9 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

AWM Investment Company held 1,076,893 shares of Definium Therapeutics worth $20.4M as of Q1 2026.
AWM Investment Company sold 313,769 Definium Therapeutics shares in Q1 2026, an estimated $5.32M.
Definium Therapeutics made up 2.25% of AWM Investment Company's portfolio in Q1 2026, its #12 holding.
AWM Investment Company first reported a position in Definium Therapeutics in Q1 2024 and has held it in 9 quarters since.
247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.